For researchers investigating the neural pathways of arousal, the PT-141 Bremelanotide 10mg peptide is the gold standard. It represents a completely unique class of sexual health compounds that target the central nervous system rather than the vascular system.
The Difference: “Hardware” vs. “Software”
Traditional medications act on the “hardware” (blood flow). If the desire isn’t there, they fail.
PT-141 (Bremelanotide) acts on the “software” (the brain). It is a melanocortin receptor agonist that “turns on” the neural signals for desire.
This makes it uniquely effective for:
- Women with HSDD: Addressing the lack of interest or desire.
- Men with Psychological ED: Where performance anxiety or lack of libido is the root cause.
Research & Handling Data
- Reconstitution: The vial contains a delicate lyophilized powder. It must be reconstituted gently with Bacteriostatic Water. Do not shake; swirl gently.
- Storage: Store the powder in the freezer. Once reconstituted, keep refrigerated and use within 14-30 days to maintain peptide integrity.
Known Side Effects (Researcher Note)
Nausea: The most common side effect (reported in ~40% of subjects). This is often dose-dependent. Starting with a lower titration is common in research protocols.
Flushing: A temporary redness or warmth in the face/neck may occur shortly after administration.
View the clinical data: NIH PubMed: PT-141 (Bremelanotide) for the treatment of sexual dysfunction.
This product is sold for laboratory research purposes only. It is not approved for unsupervised human consumption. Consult a licensed medical professional.
Contraindication: Do not use in subjects with uncontrolled high blood pressure.















Reviews
There are no reviews yet.